Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Hematologic Oncology Update
00:00
Introduction
Introduction to the topic of CD20 x CD3 bispecific antibodies in non-Hodgkin Lymphoma management, featuring insights from experts and discussion on how these antibodies work.
Transcript
Play full episode
